The STI Epidemic Is Out of Control

Sexually transmitted infections (STIs) are epidemic in the U.S. This April, the CDC reported that cases of gonorrhea, chlamydia, and syphilis were at an all-time high for the sixth consecutive year. STIs affect everyone across the country and are most common in those under 25 years of age. Untreated STIs cost our society billions of dollars annually and are largely preventable.

The timely diagnosis and effective treatment of STIs are critical for individuals and for public health. Faster treatment helps people avoid serious complications like chronic pain and infertility, and aids in prevention by reducing the spread of infection to others. Most commonly in the U.S., doctors take samples and send them to a laboratory for testing. In some places it can take up to a week or more for test results to return. During that time, patients don’t know if they have an infection, can develop complications, and can unknowingly spread infection to others. In other cases where a patient has STI symptoms or recently had sex with someone with an STI, doctors have treated patients with an antibiotic injection and handful of oral antibiotics without knowing exactly what they are treating — similarly to how patients are treated in countries without advanced healthcare.

Advances in STI Testing Technology

Access to more efficient testing is key. One option is rapid point-of-care STI tests, which can be done during a clinic visit, and potentially self-administered in patients’ homes in the near future. That can greatly improve STI prevention by allowing for immediate and accurate diagnosis and treatment. Additionally, more targeted treatment can reduce the continued spread of antibiotic resistant STIs, like drug-resistant gonorrhea. Fast point-of-care tests do not require sophisticated, costly laboratories and medical staff, meaning these tests can eventually be made available in lower-resource settings, where there is an urgent need for access to accurate testing.

Recently, several fast point-of-care tests have been developed and approved for detecting STIs. Scientists have taken the enormous 6-foot tall laboratory machines used in commercial testing laboratories and shrunk the components to make a testing device the size of a computer mouse. Many can provide test results in 30 minutes. The accuracy of one such device was recently reported in a study I co-authored in The Lancet Infectious Diseases. It was found to be equal to or better than the big machines that sit in remote centralized laboratories, far from the clinic. These and other new tests also offer new opportunities to expand settings where testing can occur — through community-based outreach and at schools and jails.

Rapid home-based testing for STIs — like we have now for COVID-19 testing — is also on the horizon. Currently, we have cost-effective home-based self-collection kits for STIs where, after collection, the patient mails the kit back to the laboratory — think “23andMe” but for STIs. Now we just need a quicker option. Home-based STI testing is preferred by most patients over clinic-based testing. It is more private, easier, and increases patient satisfaction and reduces the burden on clinics. Not having to visit a clinic or doctor’s office for STI testing might be particularly attractive for younger and adolescent patients.

Other Efforts to Ensure Greater Access to Testing

Future research and publicly funded demonstration projects should study how to harness those collection methods and technologies to improve screening and treatment for STIs at population scale. Additionally, California legislators have submitted a new law to the governor that would require public and private insurance practices to reimburse patients for the cost of over-the-counter or home-based STI tests. If signed into law, this would be especially impactful for patients who can’t afford these tests.

Increased testing and access to testing is not free from costs — both financial, personal, and societal. Most STIs are without symptoms and most people with infections don’t even realize they’re infected; and many believe what they do not know cannot hurt them. For some, perhaps ignorance is bliss. But the benefits of a reduction in the number of new STI cases and the prevention of complications must be weighed against the costs associated with expanded testing, increased stigma associated with an STI diagnosis, and the increase in antibiotic consumption.

Technology has the potential to usher in a new era of STI prevention and control in the U.S. Before STI rates rise even further, let’s prioritize greater STI prevention and treatment through access to testing.

Jeffrey Klausner, MD, MPH, is a clinical professor of population and public health sciences and medicine at the University of Southern California Keck School of Medicine in Los Angeles, and a former CDC medical officer.


Klausner is medical director of Curative, a testing company, and disclosed fees from Danaher, Roche, Cepheid, Abbott, Talis Bio, Visby Medical, and Phase Scientific. He has previously received funding from the NIH, CDC, and private test manufacturers and pharmaceutical companies to study new ways to detect and treat infectious diseases.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
5 Sarah Azhari-style Beach Outfits that Are More Sexy Living in America thumbnail

5 Sarah Azhari-style Beach Outfits that Are More Sexy Living in America

OUTFIT ke pantai ala Sarah Azhari, pernah terpikir untuk mencoba menirunya? Ya, Sarah Azhari memang dikenal menyukai penampilan dengan padupadan outfit seksi yang juga cocok untuk dijadikan sebagai referensi ketika Anda ingin ke pantai. Sarah Azhari kini telah tinggal di Los Angeles, Amerika Serikat. Gaya penampilannya semakin seksi, termasuk saat jalan-jalan ke pantai.  Nah, bagi…
Read More
15 places to report cryptocurrency exchanges…  Business suspension from the 25th of non-reported businesses thumbnail

15 places to report cryptocurrency exchanges… Business suspension from the 25th of non-reported businesses

사진=연합뉴스 특정 금융거래정보의 보고 및 이용 등에 관한 법률에 따른 가상자산 사업자 신고 기한인 24일까지 10여곳의 사업자가 금융당국에 신고를 접수했다. 이날까지 신고하지 못한 가상자산 사업자(가상화폐 거래소·지갑사업자 등)는 내일부터 영업을 중단해야 한다. 금융정보분석원(FIU)에 따르면 이날 오후 3시 기준으로 시중의 거래소 66곳 중 FIU에 신고를 마친 곳은 총 15곳이다. 업비트(두나무)·빗썸(빗썸코리아)·코인원(코인원)·코빗(코빗) 등 4대 거래소와 플라이빗(한국디지털거래소) 등 5곳이 추석…
Read More
Why Do Politicians Weaponize Medicare? Because It Works thumbnail

Why Do Politicians Weaponize Medicare? Because It Works

The Medicare wars are back, and almost no one in Washington is surprised. This time it’s Democrats accusing Republicans of wanting to maim the very popular federal health program that covers 64 million seniors and people with disabilities. In the past, Republicans have successfully pinned Democrats as the threat to Medicare. Why do politicians persistently
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?